CRIS Current Research Information System

LODATO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.480
EU - Europa 1.778
AS - Asia 1.007
AF - Africa 126
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.470
GB - Regno Unito 533
VN - Vietnam 362
SE - Svezia 292
CN - Cina 275
IT - Italia 216
SG - Singapore 209
DE - Germania 207
UA - Ucraina 112
IN - India 98
IE - Irlanda 84
RU - Federazione Russa 80
FR - Francia 66
CH - Svizzera 50
EE - Estonia 43
ZA - Sudafrica 41
TG - Togo 39
JO - Giordania 26
CI - Costa d'Avorio 20
NG - Nigeria 18
BG - Bulgaria 17
FI - Finlandia 17
BE - Belgio 16
GR - Grecia 15
JP - Giappone 11
PL - Polonia 11
CA - Canada 10
IR - Iran 10
SC - Seychelles 8
KR - Corea 6
NL - Olanda 5
CZ - Repubblica Ceca 4
BR - Brasile 3
ES - Italia 3
AU - Australia 2
BD - Bangladesh 2
DK - Danimarca 2
HR - Croazia 2
NO - Norvegia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EC - Ecuador 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
LB - Libano 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 5.399
Salva come PNG Salva come JPEG
Città #
Southend 487
Chandler 339
Fairfield 285
Dong Ket 242
Ashburn 184
Singapore 184
Santa Clara 132
Houston 128
Wilmington 110
Woodbridge 103
Ann Arbor 99
Seattle 98
Princeton 93
Dublin 84
Boardman 74
Cambridge 73
Jacksonville 68
Westminster 48
Bern 47
Lomé 39
Nanjing 39
Padova 33
Medford 32
Saint Petersburg 32
Amman 26
Berlin 25
Dearborn 25
Abidjan 20
Abeokuta 18
Beijing 17
Bologna 17
Shenyang 17
Sofia 17
Bremen 16
Brussels 16
Hebei 16
Helsinki 16
Jinan 16
Milan 16
Florence 15
Nanchang 14
Turin 14
New York 11
Tokyo 11
Falls Church 10
Jiaxing 10
Torino 10
Mülheim 9
Norwalk 9
Shanghai 9
Changsha 8
Guangzhou 8
Mahé 8
Pune 8
San Diego 8
Monmouth Junction 7
Mountain View 7
Redwood City 7
Rome 7
Tianjin 7
Zhengzhou 7
Augusta 6
Des Moines 6
Haikou 6
Hangzhou 6
Leawood 6
Falkenstein 5
Lanzhou 5
Los Angeles 5
Ningbo 5
Redmond 5
Toronto 5
Xi'an 5
Castelnuovo Rangone 4
Chengdu 4
Fuzhou 4
Moscow 4
Prague 4
Verona 4
Ardabil 3
Chicago 3
Cisterna Di Latina 3
Gangnam-gu 3
Groningen 3
Hanover 3
Olalla 3
Shijiazhuang 3
Taiyuan 3
Zanjan 3
Andover 2
Arlington 2
Athens 2
Changchun 2
Hefei 2
Henderson 2
Izmir 2
Khulna 2
Kuban 2
Kunming 2
London 2
Totale 3.676
Salva come PNG Salva come JPEG
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 219
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 216
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 192
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 187
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 184
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 175
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 172
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 162
Adverse effects of proton pump inhibitors. 161
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 148
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 147
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 139
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 134
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 132
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 132
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 130
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 124
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 122
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 117
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 113
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 112
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 111
Pharmacological modulation of MRP2 in primary biliary cirrhosis 110
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 110
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 108
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 105
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 102
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 100
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 100
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 99
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 98
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 94
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 93
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 93
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 92
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 91
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 89
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression 85
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 85
Placental MRP2 is upregulated by UDCA in cholestasis of pregnancy. 84
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 84
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 82
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 76
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 71
Outcomes and survival after TIPS positioning: a single center experience 68
Outcomes and survival after TIPS positioning: a single center experience 66
Totale 5.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020752 0 0 0 0 0 143 133 157 133 68 44 74
2020/2021742 123 48 17 24 3 21 15 32 72 21 23 343
2021/20221.072 125 49 63 63 76 71 18 48 35 52 283 189
2022/20231.187 122 185 63 155 71 97 31 63 191 30 86 93
2023/2024264 13 45 13 34 19 59 9 13 28 13 9 9
2024/2025590 45 185 80 56 175 49 0 0 0 0 0 0
Totale 5.514